Abstract
Objective To investigate the effect of flavopiridol on the proliferation, invasiveness and apoptosis of human prostate cancer cell line LNCaP, and to explore the possibility of its application in clinical treatment. Methods MTT assay was used to detect cell proliferation, cell invasion in vitro was detected by Transwell assay, and flow cytometer was used to observe apoptosis. Results Flavopiridol inhibited the growth of LNCaP cells in a concentration-dependent and time-dependent way (P < 0.05), and reduced the ability of invasion capacity. After treated by 10 nmol/L flavopiridol for 24 h, the apoptosis rate was increased significantly to (7.5±0.9) % compared with the control group [(5.3±0.5) %] (P < 0.05). Conclusion Flavopiridol can inhibit proliferation of LNCaP cells and induce apoptosis, which may be applicable for the treatment of prostate cancer. Key words: Prostatic neoplasms; Flavopiridol; Proliferation; Apoptosis; Invasiveness
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
